CR9324A - Preparación farmacéutica para la anticoncepción oral - Google Patents
Preparación farmacéutica para la anticoncepción oralInfo
- Publication number
- CR9324A CR9324A CR9324A CR9324A CR9324A CR 9324 A CR9324 A CR 9324A CR 9324 A CR9324 A CR 9324A CR 9324 A CR9324 A CR 9324A CR 9324 A CR9324 A CR 9324A
- Authority
- CR
- Costa Rica
- Prior art keywords
- pharmaceutical preparation
- dienogest
- ethinyl estradiol
- conception
- oral anti
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una preparación farmacéutica para la anticoncepción oral, que contiene cono primer componente de principio activo 17a-cianometil-l7-B-hidroxiestra-4, 9-dien-3-ona (dienogest) en una dosis diaria de 1,5 mg de dienogest y como segundo componente de principio activo 17a- etinilestradiol (etinilestradiol) en una dosis diaria de 0,015 ó 0,020 mg de etinilestradiol o 2,0 mg de dienogest y 0,015 mg de etinilestradiol, se administra junto con uno o varios portadores farmacéuticamente aceptables en al menos 21 días de un ciclo menstrual de 28 días. Además, la preparación farmacéutica contiene 7 o menos unidades de dosis diarias sin principio activo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05003179A EP1690543A1 (de) | 2005-02-15 | 2005-02-15 | Pharmazeutisches Präparat zur Kontrazeption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9324A true CR9324A (es) | 2007-10-11 |
Family
ID=34933759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9324A CR9324A (es) | 2005-02-15 | 2007-08-17 | Preparación farmacéutica para la anticoncepción oral |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1690543A1 (es) |
| JP (1) | JP2008527018A (es) |
| KR (1) | KR20070086380A (es) |
| CN (1) | CN101119732A (es) |
| AR (1) | AR053545A1 (es) |
| AU (1) | AU2006215818A1 (es) |
| BR (1) | BRPI0606724A2 (es) |
| CA (1) | CA2590004A1 (es) |
| CR (1) | CR9324A (es) |
| DO (1) | DOP2006000035A (es) |
| EA (1) | EA200701091A1 (es) |
| IL (1) | IL183635A0 (es) |
| MX (1) | MX2007009061A (es) |
| NO (1) | NO20072687L (es) |
| PA (1) | PA8663401A1 (es) |
| PE (1) | PE20061291A1 (es) |
| TW (1) | TW200640468A (es) |
| UA (1) | UA85003C2 (es) |
| WO (1) | WO2006087173A1 (es) |
| ZA (1) | ZA200707910B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1774970A1 (de) * | 2005-10-13 | 2007-04-18 | Bayer Schering Pharma AG | Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest |
| US20090099144A1 (en) * | 2007-10-11 | 2009-04-16 | Katrin Mittmann | Oral contraception (long-cycle regimen and 21-days-regimen with 30 mg ethinylestradiol and 2 mg dienogest) without treatment of thrombosis/hemostasis |
| EP2055306A1 (de) * | 2007-11-05 | 2009-05-06 | Bayer Schering Pharma AG | Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000515890A (ja) * | 1996-07-26 | 2000-11-28 | アメリカン・ホーム・プロダクツ・コーポレイション | プロゲスチンとエストロゲンとの混合剤からなる一相性避妊法およびキット |
-
2005
- 2005-02-15 EP EP05003179A patent/EP1690543A1/de not_active Withdrawn
-
2006
- 2006-02-13 DO DO2006000035A patent/DOP2006000035A/es unknown
- 2006-02-15 TW TW095105106A patent/TW200640468A/zh unknown
- 2006-02-15 PE PE2006000182A patent/PE20061291A1/es not_active Application Discontinuation
- 2006-02-15 EA EA200701091A patent/EA200701091A1/ru unknown
- 2006-02-15 KR KR1020077013786A patent/KR20070086380A/ko not_active Application Discontinuation
- 2006-02-15 PA PA20068663401A patent/PA8663401A1/es unknown
- 2006-02-15 WO PCT/EP2006/001354 patent/WO2006087173A1/de active Application Filing
- 2006-02-15 JP JP2007551646A patent/JP2008527018A/ja not_active Withdrawn
- 2006-02-15 AU AU2006215818A patent/AU2006215818A1/en not_active Abandoned
- 2006-02-15 AR ARP060100527A patent/AR053545A1/es unknown
- 2006-02-15 MX MX2007009061A patent/MX2007009061A/es not_active Application Discontinuation
- 2006-02-15 CA CA002590004A patent/CA2590004A1/en not_active Abandoned
- 2006-02-15 CN CNA2006800048911A patent/CN101119732A/zh active Pending
- 2006-02-15 BR BRPI0606724-7A patent/BRPI0606724A2/pt not_active IP Right Cessation
- 2006-02-15 EP EP06706958A patent/EP1853273A1/de not_active Ceased
- 2006-02-15 UA UAA200709517A patent/UA85003C2/ru unknown
-
2007
- 2007-05-25 NO NO20072687A patent/NO20072687L/no not_active Application Discontinuation
- 2007-06-04 IL IL183635A patent/IL183635A0/en unknown
- 2007-08-17 CR CR9324A patent/CR9324A/es unknown
- 2007-09-14 ZA ZA200707910A patent/ZA200707910B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL183635A0 (en) | 2007-10-31 |
| TW200640468A (en) | 2006-12-01 |
| MX2007009061A (es) | 2007-09-11 |
| EP1853273A1 (de) | 2007-11-14 |
| AR053545A1 (es) | 2007-05-09 |
| EA200701091A1 (ru) | 2008-02-28 |
| CN101119732A (zh) | 2008-02-06 |
| PE20061291A1 (es) | 2006-12-07 |
| KR20070086380A (ko) | 2007-08-27 |
| NO20072687L (no) | 2007-11-13 |
| WO2006087173A1 (de) | 2006-08-24 |
| EP1690543A1 (de) | 2006-08-16 |
| DOP2006000035A (es) | 2006-09-15 |
| PA8663401A1 (es) | 2006-12-07 |
| UA85003C2 (ru) | 2008-12-10 |
| ZA200707910B (en) | 2009-08-26 |
| AU2006215818A1 (en) | 2006-08-24 |
| JP2008527018A (ja) | 2008-07-24 |
| CA2590004A1 (en) | 2006-08-24 |
| BRPI0606724A2 (pt) | 2009-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2693085T1 (es) | Uso de estriol en bajas dosis | |
| HRP20070188A2 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
| AR061959A1 (es) | Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas | |
| CR9324A (es) | Preparación farmacéutica para la anticoncepción oral | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| EA200701389A1 (ru) | Твёрдая пероральная лекарственная форма для контрацепции | |
| DOP2006000037A (es) | Forma farmacológica peroral sólida para la anticoncepción | |
| UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
| CR10912A (es) | Preparacion framaceutica para reducir la endometriosis | |
| DOP2007000122A (es) | Forma farmacologica peroral para anticoncepcion | |
| CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
| PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa | |
| TH80557B (th) | ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก | |
| TH80557A (th) | ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก | |
| TH54054B (th) | สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด | |
| ECSP003721A (es) | Una composicion farmaceutica para ser usada como anticonceptivo | |
| TH80558B (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
| CR9240A (es) | Forma farmacologica peroral solida para la anticoncepcion | |
| TH80558A (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
| RS50849B (sr) | Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu | |
| TH148141A (th) | การใช้เอสตราไดออลวาเลอเรตหรือเอสตราไดออลร่วมกับไดอีโนเจสต์สำหรับการรักษาโดยให้ทางปากในการตกเลือดในมดลูกแบบที่ทำงานผิดปกติ ร่วมกับยาคุมกำเนิดสำหรับให้ทางปาก |